Literature DB >> 30237306

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.

Victor Kim1, Shawn D Aaron2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic illness that can be periodically punctuated by exacerbations, characterised by acute worsening of symptoms, including increased dyspnoea, cough, sputum production and sputum purulence. COPD exacerbations are common and have important clinical and economic consequences, including lost work productivity, increased utilisation of healthcare resources, temporary or permanent reductions in lung function and exercise capacity, hospitalisation, and sometimes death. Over the past two decades, clinicians and researchers have broadened their treatment goals for COPD to extend beyond improving lung function and symptoms, and have begun to address the importance of preventing and reducing exacerbations. However, despite the best efforts of clinicians and guideline committees, current definitions of COPD exacerbations are imperfect and fraught with problems. The cardinal symptoms of a COPD exacerbation are nonspecific and can result from acute cardiorespiratory illnesses other than COPD. A proposed definition, which may be more specific than current definitions, suggests that COPD exacerbation be defined as an acute or subacute worsening of dyspnoea (≥5 on a visual analogue scale that ranges from 0 to 10) sometimes but not necessarily accompanied by increased cough, sputum volume and/or sputum purulence. Necessary laboratory criteria for an exacerbation include oxygen desaturation ≤4% below that of stable state, elevated levels of circulating blood neutrophils or eosinophils (≥9000 neutrophils·mm-3 or ≥2% blood eosinophils) and elevated C-reactive protein (≥3 mg·L-1), without evidence of pneumonia or pulmonary oedema on chest radiography and with negative laboratory test results for other aetiologies. Herein, we discuss the current state of the art with respect to how we define COPD exacerbations, associated pitfalls and challenges, and opportunities for improvement.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30237306     DOI: 10.1183/13993003.01261-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.

Authors:  Jianlan Hua; Wei Zhang; Hui-Fang Cao; Chun-Ling Du; Jia-Yun Ma; Yi-Hui Zuo; Jing Zhang
Journal:  BMJ Open       Date:  2020-05-07       Impact factor: 2.692

2.  Validity of the diagnosis of pneumonia in hospitalised patients with COPD.

Authors:  Lydia J Finney; Vijay Padmanaban; Samuel Todd; Nadia Ahmed; Sarah L Elkin; Patrick Mallia
Journal:  ERJ Open Res       Date:  2019-06-24

Review 3.  Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation.

Authors:  Rodrigo Vazquez Guillamet
Journal:  Medicina (Kaunas)       Date:  2019-09-26       Impact factor: 2.430

4.  Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.

Authors:  June Hong Ahn; Jin Hong Chung; Kyeong-Cheol Shin; Eun Young Choi; Hyun Jung Jin; Mi Suk Lee; Mi Jeong Nam; Kwan Ho Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-02

5.  A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation.

Authors:  Soo Han Kim; Hee-Sung Ahn; Jin-Soo Park; Jeonghun Yeom; Jiyoung Yu; Kyunggon Kim; Yeon-Mok Oh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-01

Review 6.  Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?

Authors:  Meiling Liu; Kang Wu; Jinduan Lin; Qingqiang Xie; Yuan Liu; Yin Huang; Jun Zeng; Zhaogang Yang; Yifan Wang; Shiyan Dong; Weiye Deng; Mingming Yang; Song Wu; Wen Jiang; Xuefeng Li
Journal:  Front Pharmacol       Date:  2021-07-02       Impact factor: 5.810

7.  Breathing-Swallowing Discoordination and Inefficiency of an Airway Protective Mechanism Puts Patients at Risk of COPD Exacerbation.

Authors:  Yuki Yoshimatsu; Kazunori Tobino; Shinsuke Nagami; Naomi Yagi; Yoshitaka Oku
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-13

8.  Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.

Authors:  Alexander G Mathioudakis; Wim Janssens; Pradeesh Sivapalan; Aran Singanayagam; Mark T Dransfield; Jens-Ulrik Stæhr Jensen; Jørgen Vestbo
Journal:  Thorax       Date:  2020-03-26       Impact factor: 9.139

9.  Repetitive Saliva Swallowing Test Predicts COPD Exacerbation.

Authors:  Yuki Yoshimatsu; Kazunori Tobino; Takuto Sueyasu; Saori Nishizawa; Yuki Ko; Mina Yasuda; Hiromi Ide; Kosuke Tsuruno; Hiroyuki Miyajima
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-04

10.  Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?

Authors:  Mohsen Sadatsafavi; James McCormack; John Petkau; Larry D Lynd; Tae Yoon Lee; Don D Sin
Journal:  Eur Respir J       Date:  2021-02-11       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.